UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 9, 2024

Accession Number:	0001104659-24-028705
Submission Type:	POS AM
CIK: 0001442836 Company Name: Mersana Therapeutics, Inc. File Number: 333-271766